97 related articles for article (PubMed ID: 3519454)
1. [Protein deficiency, host defense and natural anti-tumor immunity].
Ruffmann R; Schlick E; Tartaris T; Chirigos MA
Infusionsther Klin Ernahr; 1986 Apr; 13(2):106-12. PubMed ID: 3519454
[TBL] [Abstract][Full Text] [Related]
2. Protein deficiency reduces natural antitumor immunity.
Ruffmann R; Schlick E; Tartaris T; Budzynski W; Chirigos MA
Cancer Detect Prev Suppl; 1987; 1():15-27. PubMed ID: 3121178
[TBL] [Abstract][Full Text] [Related]
3. Natural cytotoxic cells against solid tumors in mice: a comparison with natural killer cells.
Stutman O; Lattime EC; Figarella EF
Fed Proc; 1981 Oct; 40(12):2699-704. PubMed ID: 7286250
[TBL] [Abstract][Full Text] [Related]
4. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immunity in nutritional deficiency.
McMurray DN
Prog Food Nutr Sci; 1984; 8(3-4):193-228. PubMed ID: 6396715
[TBL] [Abstract][Full Text] [Related]
6. [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice].
Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA
Eksp Onkol; 1986; 8(6):36-40. PubMed ID: 3803287
[TBL] [Abstract][Full Text] [Related]
7. Role of natural killer cells in host defense against cancer metastasis.
Hanna N
Symp Fundam Cancer Res; 1983; 36():309-19. PubMed ID: 6382510
[No Abstract] [Full Text] [Related]
8. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cells and their possible roles in host resistance against tumors.
Herberman RB
Transplant Proc; 1984 Apr; 16(2):476-8. PubMed ID: 6719548
[No Abstract] [Full Text] [Related]
10. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
Hummel S; Wilms D; Vitacolonna M; Zöller M
J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
[TBL] [Abstract][Full Text] [Related]
11. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
Gjedde SB
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
[TBL] [Abstract][Full Text] [Related]
12. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
Stein-Streilein J; Bennett M; Mann D; Kumar V
J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
[TBL] [Abstract][Full Text] [Related]
15. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
16. Life history of cells mediating natural resistance to tumor cells and bone-marrow transplants: the respective roles of cell lineage commitment and host environment in determining strain characteristics of natural resistance to foreign marrow grafts.
Miller SC
Am J Anat; 1984 Jul; 170(3):367-76. PubMed ID: 6383004
[TBL] [Abstract][Full Text] [Related]
17. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
Bright RK; Shearer MH; Kennedy RC
J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
[TBL] [Abstract][Full Text] [Related]
18. Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity.
Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Miyagi T; Jinushi M; Sakamori R; Kohga K; Uemura A; Ohkawa K; Storkus WJ; Hayashi N
Gene Ther; 2007 Jun; 14(11):863-71. PubMed ID: 17344900
[TBL] [Abstract][Full Text] [Related]
19. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]